Will 2021 go down as the year A2 and other milk share prices turned sour?

Infant formula used to be a booming sector. Yet, 2021 is shaping up to be a shocking year for the A2 Milk share price and other milk makers.

| More on:
falling milk asx share price represented by frowning woman tasting sour milk

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

What was once the flavour of the time, ASX-listed infant formula companies have gone off this year. To be fair to 2021, the decline had begun around the middle of last year. But that hasn't stopped this year from adding to the share price pain of companies like A2 Milk Company Ltd (ASX: A2M).

The boom of A2 Milk and infant formula share prices

There was a time when milk was like liquid gold, with the main boom from the infant formula market. If you took a quick look at the share prices of many ASX-listed infant formula makers, you'd see the initial uptick began in 2017.

From there, it was nothing but blue skies. Speculators piled in as the Chinese market showed stronger demand for Australian formulated milk. A2 Milk overtook Blackmores Ltd (ASX: BKL) in market capitalisation as the story gained pace.

Sure enough, investors turned to riskier small caps hoping to replicate the same success. Companies such as Bubs Australia Ltd (ASX: BUB) and Wattle Health (ASX: WHA) caught the coattails of the rapidly growing industry.

Until one day the growth story became growth history.

Three ASX-listed infant formula shares ravaged

Clover Corporation Ltd (ASX: CLV)

Likely the least known on this, though surprisingly not the smallest in value, Clover Corporation has handled the unfavourable environment reasonably well. For starters, the company's share price is up 17.6% year-to-date.

Clover Corp has likely benefitted from its diversified business. Although the company is focused on infant formula, its powders are also used in bread, yoghurt, health bars etc.

However, this didn't prevent the company from taking a hit to its revenue and earnings from a decrease in demand. Clover reported a 21.7% revenue decline year-on-year to $29.4 million in H1 FY21. Net profit also declined 45.8% to $2.5 million.

Bubs Australia Ltd (ASX: BUB)

Bubs were one of the small ASX-listed companies that investors clung to through the hype. Being relatively small, the company's unique goat infant formula products generated rapid revenue growth in percentage terms.

Unfortunately, Bubs' success story was highly contingent on sales into China's Daigou channel. As fate would have it, COVID-19 brought abrupt disruptions to this core growth lifeline. In the company's 1H FY21 result, it notes this was partly offset by strong local momentum. Regardless, COVID took a 23% bite out of the company's gross revenue compared to the prior corresponding period.

As you might have guessed, a small company making losses, losing its growth is devastating. The Bubs share price year-to-date reflects shareholder's disappointment — shaving off 31%.

A2 Milk Company Ltd (ASX: A2M)

The grandaddy of ASX infant formula is A2 Milk. Arguably one of the biggest success stories of the ASX in recent times, maybe behind a few tech companies. It has scaled from an over $100 million revenue company to an over $1.5 billion revenue company in the space of six years.

A2 Milk has become a household name — both from a product perspective and as an investment. But the story gave way to significant disruptions of its daigou sales channel as well. Total revenue for the company declined 16% to NZ$677.4 year-on-year.

Losing that continuous growth streak meant investors lost their willingness to pay a high premium for the A2 Milk share price, leading to a sizeable selloff. In specific terms, shares have now fallen 39.4% YTD and 64.4% from its peak.

More on Consumer Staples & Discretionary Shares

ASX 200 shares broker downgrade origami paper fortune teller with buy hold sell and dollar sign options
Consumer Staples & Discretionary Shares

Domino's shares: Buy, sell, or hold?

Should I buy Domino’s shares today or wait for a confirmed turnaround?

Read more »

a woman stands with a full grocery trolley at the top of a supermarket aisle.
Consumer Staples & Discretionary Shares

Will this secret weapon help Coles shares outperform?

This advantage could help Coles in the coming years. Here’s how.

Read more »

A young boy pushing his friend in a shopping trolley race along the road.
Broker Notes

Macquarie tips Coles shares to deliver market-beating returns

Back up the trolley! This leading broker thinks now is the time to buy.

Read more »

Woman thinking in a supermarket.
Consumer Staples & Discretionary Shares

Battle of the supermarkets: should I buy Coles or Woolworths?

Two of the heavy hitters in the supermarket industry have been moving in opposite directions to start the year.

Read more »

A happy young couple celebrate a win by jumping high above their new sofa.
Broker Notes

Which 2 ASX furniture retailers are up more than 400% in 5 years?

Time to lounge back and let these furniture retailers grow?

Read more »

Happy man on a supermarket trolley full of groceries with a woman standing beside him.
Consumer Staples & Discretionary Shares

Why are Woolworths shares racing 6% higher?

This supermarket giant is leading that way on Friday with a big gain.

Read more »

Happy couple doing online shopping.
Earnings Results

This ASX 200 stock is rising on $148m half-year profit

Another record result was recorded for Peter Alexander but Smiggle is struggling.

Read more »

Anxious people gambling
Consumer Staples & Discretionary Shares

When will Star Entertainment shares begin trading again?

Some deadlines in the financial rescue plan provide clues as to when the stock may resume trading.

Read more »